University of Cape Town
Rondebosch, Western Cape, South Africa
Purpose
To characterize the immune response to TB antigens in IGRA- and IGRA+ persons, determine the immunogenicity and putative protection in preclinical models, and use this information to rationally design a novel TB vaccine construct.
Division
Global Health
Date
November 2024
Region Served
GLOBAL
Committed amount
$1,746,512
Grant topic
Discovery and Translational Sciences
Duration (months)
35
Grantee location
Rondebosch, Western Cape, South Africa
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.